Parkinson's Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. It affects 3% to 4% of the population over the age of 65 years.
SERVICES
Biomarkers
Prodromal PD Biomarkers
- Non-motor symptoms
- Hyposmia (olfactory deficits)
- Visual abnormalities (oculomotor disturbances)
- Neuropsychiatric symptoms:
- Depression
- Anxiety
- Anhedonia
- Orthostatic Hypotension
- Sleep disorders
- Constipation
- Urogenital Dysfunction
- Mood disorders
- Neurobehavioral abnormalities
Clinical Biomarkers
- Motor Symptoms
- Akinesia
- Bradykinesia
- Hypokinesia
- Postural Instability
- Rigidity
- Stopped Posture
- Tremor at rest
- Gait Impairment
- Stiffness of arms, legs and trunk
- Poor balance and coordination
Preclinical Biomarkers
- Molecular imaging
- DAT SPECT
- Florodopa PET scan
- Transcranial sonography
- Magnetic Resonance Imaging
- Optical Resonance Tomography
- Biochemical Biomarkers
- Genetic Biomarkers
Our approach
is a carefully validated, clinically realistic model for early diabetes mellitus screening and managing of the disease.
Our mathematical & computational tools
enable researchers and decision makers to make better informed decisions.
